Table 2.
Characteristics of patients with MES 0 vs MES 1-3
| Characteristics | MES 0 | MES 1-3 | P value |
| (n = 94) | (n = 100) | ||
| Gender, n (%) | |||
| Male | 54 (57) | 45 (45) | 0.083 |
| Female | 40 (43) | 55 (55) | |
| Median age, yr (IQR) | 46 (32-60) | 41 (33-51) | 0.051 |
| Median duration of disease, mo (IQR) | 99 (53-198) | 112 (44-191) | 0.950 |
| Median age at onset, yr (IQR) | 34 (22-47) | 31 (22-40) | 0.130 |
| Median duration of sustaining clinical remission at the time of colonoscopy, mo (IQR) | 17 (9-33) | 9 (4-13) | < 0.0001 |
| Extent of disease, n (%) | |||
| Pancolitis | 59 (63) | 66 (66) | 0.340 |
| Left-side colitis | 27 (29) | 21 (21) | |
| Proctitis | 8 (8) | 13 (13) | |
| Concomitant medications, n (%) | |||
| Aminosalicylate | 86 (91) | 92 (92) | 0.900 |
| Corticosteroids | 11 (12) | 16 (16) | 0.390 |
| Mercaptopurine/Azathioprine | 45 (48) | 34 (34) | 0.049 |
| Tacrolimus | 4 (4) | 6 (6) | 0.580 |
| Biologics | 2 (2) | 7 (7) | 0.110 |
| Fecal Hb concentrations (ng/mL) | 50 (4-50) | 315 (108-1277) | < 0.0001 |
MES: Mayo endoscopic subscore; Hb: Hemoglobin; IQR: Interquartile range.